Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.43%GBPTRY+0.41%NZDCHF+0.41%USDCAD-0.39%EURCAD-0.34%CADJPY+0.34%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%AUDSGD+0.28%USDTRY+0.28%EURCHF+0.27%NZDSGD+0.25%CHFJPY-0.25%GBPJPY+0.24%NZDUSD+0.23%AUDUSD+0.22%EURGBP-0.22%USDCHF+0.21%USDNOK-0.21%NZDCAD-0.20%GBPSGD+0.19%NZDMXN+0.18%USDZAR-0.18%AUDJPY+0.17%AUDCAD-0.17%EURSGD+0.16%USDILS+0.16%NZDJPY+0.16%NOKJPY+0.16%CHFSGD+0.15%USDPLN-0.15%USDSEK-0.15%EURAUD-0.14%CHFNOK-0.12%AUDDKK+0.12%EURNZD-0.12%SGDJPY-0.11%EURNOK-0.11%PLNJPY+0.10%EURHKD+0.10%USDDKK-0.10%GBPAUD+0.09%EURZAR-0.08%GBPCAD-0.08%EURCNH+0.07%GBPNZD+0.07%USDTHB+0.07%EURUSD+0.06%USDSGD+0.06%CHFSEK-0.06%GBPZAR-0.06%EURPLN-0.05%EURSEK-0.05%USDJPY-0.05%USDCOP-0.04%EURJPY+0.02%AUDNZD+0.02%USDCNH-0.02%USDMXN-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK+0.01%EURDKK0.00%COTTON+0.90%HG1+0.74%S1+0.42%XNGUSD+0.41%UKOIL-0.27%USOIL-0.26%W1-0.25%XAGUSD+0.09%GAGUSD+0.09%C1-0.05%GAUUSD+0.04%XAUUSD+0.04%BTCUSD+2.52%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.78%DOGEUSD+14.12%XMRUSDT+5.57%LINKUSD+13.42%XLMUSD+0.29%BCHUSDT+5.71%UNIUSD+7.23%LTCUSD+9.66%SUIUSD+3.56%HBARUSDT+0.50%TONUSD+26.15%TAOUSDT+3.92%AAVEUSD+3.69%DOTUSDT+0.06%ICPUSDT+0.56%ONDOUSDT+0.47%WLDUSDT+0.17%ARBUSDT+7.07%JUPUSDT+0.62%ATOMUSDT+1.62%INJUSDT+14.60%STXUSDT+5.78%FETUSDT+3.07%TIAUSDT+9.38%PYTHUSDT-0.53%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+3.94%IOTAUSDT+0.81%WIFUSDT+2.70%AXSUSDT-1.66%POLUSDT+2.83%FARTCOINUSDT+1.01%EOSUSDT+2.16%DYDXUSDT+3.68%GALAUSDT-1.87%ORDIUSDT+0.11%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.43%GBPTRY+0.41%NZDCHF+0.41%USDCAD-0.39%EURCAD-0.34%CADJPY+0.34%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%AUDSGD+0.28%USDTRY+0.28%EURCHF+0.27%NZDSGD+0.25%CHFJPY-0.25%GBPJPY+0.24%NZDUSD+0.23%AUDUSD+0.22%EURGBP-0.22%USDCHF+0.21%USDNOK-0.21%NZDCAD-0.20%GBPSGD+0.19%NZDMXN+0.18%USDZAR-0.18%AUDJPY+0.17%AUDCAD-0.17%EURSGD+0.16%USDILS+0.16%NZDJPY+0.16%NOKJPY+0.16%CHFSGD+0.15%USDPLN-0.15%USDSEK-0.15%EURAUD-0.14%CHFNOK-0.12%AUDDKK+0.12%EURNZD-0.12%SGDJPY-0.11%EURNOK-0.11%PLNJPY+0.10%EURHKD+0.10%USDDKK-0.10%GBPAUD+0.09%EURZAR-0.08%GBPCAD-0.08%EURCNH+0.07%GBPNZD+0.07%USDTHB+0.07%EURUSD+0.06%USDSGD+0.06%CHFSEK-0.06%GBPZAR-0.06%EURPLN-0.05%EURSEK-0.05%USDJPY-0.05%USDCOP-0.04%EURJPY+0.02%AUDNZD+0.02%USDCNH-0.02%USDMXN-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK+0.01%EURDKK0.00%COTTON+0.90%HG1+0.74%S1+0.42%XNGUSD+0.41%UKOIL-0.27%USOIL-0.26%W1-0.25%XAGUSD+0.09%GAGUSD+0.09%C1-0.05%GAUUSD+0.04%XAUUSD+0.04%BTCUSD+2.52%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.78%DOGEUSD+14.12%XMRUSDT+5.57%LINKUSD+13.42%XLMUSD+0.29%BCHUSDT+5.71%UNIUSD+7.23%LTCUSD+9.66%SUIUSD+3.56%HBARUSDT+0.50%TONUSD+26.15%TAOUSDT+3.92%AAVEUSD+3.69%DOTUSDT+0.06%ICPUSDT+0.56%ONDOUSDT+0.47%WLDUSDT+0.17%ARBUSDT+7.07%JUPUSDT+0.62%ATOMUSDT+1.62%INJUSDT+14.60%STXUSDT+5.78%FETUSDT+3.07%TIAUSDT+9.38%PYTHUSDT-0.53%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+3.94%IOTAUSDT+0.81%WIFUSDT+2.70%AXSUSDT-1.66%POLUSDT+2.83%FARTCOINUSDT+1.01%EOSUSDT+2.16%DYDXUSDT+3.68%GALAUSDT-1.87%ORDIUSDT+0.11%RONINUSDT-3.42%NOTUSDT+1.21%
ET

Edgewise Therapeutics, Inc. (EWTX)

NASDAQ • Healthcare

$36.28
-$2.17 (-5.6%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$38.17
Day Range$36.08 - $38.35
Avg. Volume (3M)1.7M
Market Cap$3.9B
52 Week Range
$14.68$48.51
Next EarningsIn 22 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$197.2M
EPS (TTM)
-$1.85
ROA (TTM)
-41.11%
Current Ratio
16.24

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-9.3%Q1 2026-$0.47
+8.0%Q2 2026-$0.46
-13.3%Q3 2026-$0.53
Next

Nov 5

in 22 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -13.3%

Edgewise Therapeutics’ preliminary results for the second fiscal quarter of 2026 showed a wider loss than expected, with EPS of -$0.53 trailing the -$0.47 estimate, -13%, when it reported on August 6, 2026. Net income was a loss of roughly $57.3 million, down 58.7% year over year from a loss of about $36.1 million a year ago, while EPS declined 55.9% from -$0.34. Operating income came in at a loss of about $61.9 million, and the company posted negative operating cash flow of roughly $43.5 million. For the next period, consensus calls for EPS of -$0.55 on revenue of $129.2 million.

Next report — what to expect

Edgewise Therapeutics, Inc. reports earnings on November 5, 2026. Wall Street is looking for consensus EPS of -$0.533 on revenue of $129.2 million. In recent history, the company has beaten EPS estimates in 5 of its 8 most recent quarters, making estimate variance a key item to monitor alongside any revenue update.

View full earnings history

About Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. is a NASDAQ-listed biotechnology company focused on small-molecule medicines for muscle disease. In qualitative terms, it is an early-stage healthcare developer, and its lead program is EDG-5506, an orally administered compound being studied for dystrophinopathies and other genetically defined muscle conditions.

Name
Edgewise Therapeutics, Inc.
CEO
Kevin Koch
Website
www.edgewisetx.com
Industry
Healthcare
Year Founded
2017
Employees
127

Today's Snapshot

AI-generated

The day ended with EWTX 5.6% lower at 36.28, in line with a weaker sector. Trading was lighter than usual, with volume about two-thirds of its usual level.

Trading Volume

Below 10d avg (1.4M)

810.1K

vs S&P 500 Today

Strong Underperformance

-5.62%

Updated: October 13, 2026 at 20:33 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
EWTX is under pressure with the market trading near 36.3 and short- and medium-term moving averages above the current price, although the 200-day average lies slightly below, creating conflicting longer-term context. Momentum and MACD are negative and CCI is oversold, while RSI hovers near the low 30s, indicating weak buying interest. ADX is low, suggesting limited trend strength, and on-balance volume is negative, consistent with distribution; ATR is relatively high at about a 5.5% range. The pivot level sits above the market and acts as nearby resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$34.77 - $41.28
    Sell
  • RSI (14)30.15
    Neutral
  • Stochastic %K (14, 3, 3)13.66
    Buy
  • MACD Level (12, 26)-1.33
    Sell

Peers & Related Assets

PTCTPTC Therapeutics, Inc.
$59.89-4.8%
DYNDyne Therapeutics, Inc.
$15.3-4.1%
SRPTSarepta Therapeutics, Inc.
$16.51-5.3%
STOKStoke Therapeutics, Inc.
$22.5-6.8%
SLDBSolid Biosciences Inc.
$5.82-13.3%
CAPRCapricor Therapeutics, Inc.
$6.88-7.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.